Although an acute opioid withdrawal markedly modifies LH secretion in the different phases of the menstrual cycle, whether a sustained opioid blockade imbalances spontaneous LH modifications associated with the progression of the follicular or luteal menstrual phases is presently unknown. Accordingly, normal cycling women during either the follicular (n = 14) or luteal (n = 14) menstrual phase, randomly and in double blind fashion, received either placebo (n = 7 for each phase) or 50 mg/day of the oral opioid antagonist naltrexone (n = 7 for each phase). In each subject, LH pulsatility (10-min blood drawing for 8 h) and the pituitary LH response to a 10-micrograms GnRH stimulus were investigated at baseline and on the fifth day of placebo/n...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
This study evaluated the activity of central opiate receptors modulating luteinizing hormone (LH) se...
Endogenous opioid peptides have a tonic inhibitory control on LH secretion, participating in the fun...
Although an acute opioid withdrawal markedly modifies LH secretion in the different phases of the me...
To investigate whether enhanced LH levels of women with polycystic ovarian syndrome (PCOS) are the c...
The present study was designed to evaluate the influence of hyperandrogenemia on the activity of the...
A number of studies have been made on the role played by endogenous opioid peptides in the secretion...
The observation that heroin-addicted subjects are amenorrheic and/or hypogonadic suggested a possibl...
With the aim of examining central opioid influences on the control of luteinizing hormone (LH) secre...
Women often exhibit larger hormonal and subjective responses to opioid receptor antagonists than men...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
Endogenous opioid peptides have a tonic inhibitory control on LH secretion, participating in the fun...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
This study evaluated the activity of central opiate receptors modulating luteinizing hormone (LH) se...
Endogenous opioid peptides have a tonic inhibitory control on LH secretion, participating in the fun...
Although an acute opioid withdrawal markedly modifies LH secretion in the different phases of the me...
To investigate whether enhanced LH levels of women with polycystic ovarian syndrome (PCOS) are the c...
The present study was designed to evaluate the influence of hyperandrogenemia on the activity of the...
A number of studies have been made on the role played by endogenous opioid peptides in the secretion...
The observation that heroin-addicted subjects are amenorrheic and/or hypogonadic suggested a possibl...
With the aim of examining central opioid influences on the control of luteinizing hormone (LH) secre...
Women often exhibit larger hormonal and subjective responses to opioid receptor antagonists than men...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
Endogenous opioid peptides have a tonic inhibitory control on LH secretion, participating in the fun...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
This study evaluated the activity of central opiate receptors modulating luteinizing hormone (LH) se...
Endogenous opioid peptides have a tonic inhibitory control on LH secretion, participating in the fun...